Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
Collaboration will evaluate Akeso's cadonilimab in combination with INOVIO's INO-5412 (INO-5401 plus INO-9012) as a potential treatment for glioblastoma (GBM), the most common and aggressive form of brain cancer Novel combination therapy will be...
e& and IBM Unveil Enterprise-Grade Agentic AI to Transform Governance and Compliance
Announced at the World Economic Forum in Davos, the deployment marks e&'s move beyond traditional chatbots to enterprise-grade agentic AI. Powered by IBM watsonx Orchestrate, agentic AI is embedded into mission-critical governance and compliance...